GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » Beneish M-Score

Cannabist Company Holdings (Cannabist Company Holdings) Beneish M-Score : -2.59 (As of May. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.59 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Cannabist Company Holdings's Beneish M-Score or its related term are showing as below:

CBSTF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.21   Med: -2.16   Max: 2.62
Current: -2.59

During the past 6 years, the highest Beneish M-Score of Cannabist Company Holdings was 2.62. The lowest was -3.21. And the median was -2.16.


Cannabist Company Holdings Beneish M-Score Historical Data

The historical data trend for Cannabist Company Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Beneish M-Score Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - 2.62 -1.72 -3.21 -2.59

Cannabist Company Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.09 -2.94 -2.36 -2.59 -

Competitive Comparison of Cannabist Company Holdings's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's Beneish M-Score falls into.



Cannabist Company Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Cannabist Company Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8299+0.528 * 1.0849+0.404 * 0.8072+0.892 * 0.9929+0.115 * 1.1329
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7885+4.679 * -0.101685-0.327 * 1.1646
=-3.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $10.5 Mil.
Revenue was 122.611 + 128.365 + 129.183 + 129.244 = $509.4 Mil.
Gross Profit was 42.537 + 43.623 + 37.142 + 52.122 = $175.4 Mil.
Total Current Assets was $189.9 Mil.
Total Assets was $812.8 Mil.
Property, Plant and Equipment(Net PPE) was $504.8 Mil.
Depreciation, Depletion and Amortization(DDA) was $61.6 Mil.
Selling, General, & Admin. Expense(SGA) was $163.7 Mil.
Total Current Liabilities was $166.0 Mil.
Long-Term Debt & Capital Lease Obligation was $527.1 Mil.
Net Income was -35.073 + -72.784 + -36.725 + -28.863 = $-173.4 Mil.
Non Operating Income was -4.99 + -81.418 + -0.053 + -8.996 = $-95.5 Mil.
Cash Flow from Operations was -6.211 + 9.38 + 1.809 + -0.313 = $4.7 Mil.
Total Receivables was $12.8 Mil.
Revenue was 124.535 + 126.187 + 132.733 + 129.571 = $513.0 Mil.
Gross Profit was 47.081 + 41.601 + 52.135 + 50.848 = $191.7 Mil.
Total Current Assets was $238.5 Mil.
Total Assets was $973.0 Mil.
Property, Plant and Equipment(Net PPE) was $559.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $78.6 Mil.
Selling, General, & Admin. Expense(SGA) was $209.0 Mil.
Total Current Liabilities was $172.4 Mil.
Long-Term Debt & Capital Lease Obligation was $540.1 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(10.542 / 509.403) / (12.794 / 513.026)
=0.020695 / 0.024938
=0.8299

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(191.665 / 513.026) / (175.424 / 509.403)
=0.373597 / 0.344372
=1.0849

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (189.887 + 504.793) / 812.831) / (1 - (238.479 + 559.332) / 973.021)
=0.145357 / 0.180068
=0.8072

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=509.403 / 513.026
=0.9929

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(78.641 / (78.641 + 559.332)) / (61.63 / (61.63 + 504.793))
=0.123267 / 0.108806
=1.1329

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(163.665 / 509.403) / (209.039 / 513.026)
=0.321288 / 0.407463
=0.7885

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((527.093 + 165.979) / 812.831) / ((540.059 + 172.363) / 973.021)
=0.852664 / 0.732175
=1.1646

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-173.445 - -95.457 - 4.665) / 812.831
=-0.101685

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Cannabist Company Holdings has a M-score of -3.15 suggests that the company is unlikely to be a manipulator.


Cannabist Company Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings (Cannabist Company Holdings) Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc Formerly Columbia Care Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under Amber, ClaraCeed, Press, Platinum label, Platinum Partners, Seed & Starin, and Triple 777 brands.
Executives
Alison Worthington director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson officer: Chief People/Admin Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita director, officer: Chief Executive Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jeff Clarke director COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson officer: Chief Financial Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet officer: Chief Scientific Officer 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
David Sirolly officer: Chief Legal Officer/GC C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Guy Hussussian officer: Chief Data Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon officer: Chief Growth Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart officer: Chief Operating Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott director, officer: Chairman C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage director
Kennedy James A C director T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204